MBD2 and prostate carcinoma: The demethylase ALKBH5 with m6A binding proteins YTHDF1/2/3, concurrently, played a suppression role in the regulation of NSCLC tumor growth and metastasis [131], while FTO inhibits tumorigenesis in prostate cancer [132].